Table 3 Summary of main studies involving patient self-management of oral anticoagulants in real-world settings
From: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
Author | Number of patients | Indication | Median Years of follow-up | Mortality a | Thromboembolic events a | Major hemorrhages a | Median TTR (%) |
|---|---|---|---|---|---|---|---|
Fritschi et al., [24] | 300 | Mixed | 2.8 | – | 0.6 | 0.6 | 72.0 |
Matchar et al., [25] | 1463 | AF, MHV | 3.0 b | 3.4 | 0.7 | 4.0 | 66.2 |
Nagler et al., [26] | 1221 | Mixed | 4.3 | 1.4 | 0.9 | 1.2 | 80.0 |
Ward et al., [27] | 296 | Mixed | 1.0 | – | – | – | 75.3 b |
Grove et al., [28] | 534 | AF | 2.5 | 1.1 | 0.5 | 2.3 | – |
Present study | 808 | Mixed | 3.3 | 2.4 | 0.9 | 0.5 | 71.5 |